Silicon Laboratories, Inc.

SLAB Technology Semiconductors

Silicon Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $784.8 million, up 34.3% from fiscal 2024. In the quarter to June 2026, revenue grew 18.3%, EPS grew 52.2% and free cash flow fell 608.1%, each against the same quarter a year earlier.

221.00 0.05 −0.02%
Market cap
$7.4B
P/E
0.0×
Fwd P/E
−120×
Dividend yield
—
F-score
6/9
Altman Z
16.64
Beneish M
−3.05
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Total current assets
490.85 947.64 826.64 943.86 975.82 2,238.57 1,461.36 737.93 602.03 674.02
Total non-current assets
590.99 587.44 797.72 730.99 1,017.67 719.72 708.07 705.13 620.64 595.30
Total Assets
1,081.84 1,535.08 1,624.35 1,674.85 1,993.49 2,958.30 2,169.43 1,443.06 1,222.67 1,269.32
Total current liabilities
139.70 162.33 144.85 137.70 284.50 668.83 185.78 163.57 97.88 143.79
Total non-current liabilities
115.19 419.74 412.22 422.10 509.15 77.04 578.64 70.80 44.77 31.11
Total liabilities
254.89 582.07 557.06 559.80 793.65 745.87 764.42 234.37 142.65 174.90
Common Equity (Total)
826.96 953.02 1,067.29 1,115.05 1,199.84 2,212.42 1,405.01 1,208.68 1,080.02 1,094.42
Shareholders Equity (Total)
826.96 953.02 1,067.29 1,115.05 1,199.84 2,212.42 1,405.01 1,208.68 1,080.02 1,094.42
Total Debt
72.50 341.88 359.77 374.26 563.43 472.60 535.57 45.00 — —

Show all line items

In millions of $ except per-share values · columns are period end dates